VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025)
VitaNova Life Sciences' (VNOV) quarterly Cash from Financing Activities came in at -$101500.0 in Q2 2025, down 320.55% YoY from $46021.1 in Q2 2024, and down 283.02% on a QoQ basis from -$26500.0 in Q1 2025.
VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025) Analysis & Trends
VitaNova Life Sciences (VNOV) has 8 years of Cash from Financing Activities data on file, last reported at -$101500.0 in Q2 2025.
- Quarterly Cash from Financing Activities fell 320.55% year-over-year to -$101500.0 in Q2 2025, while the trailing twelve-month figure through Jan 2026 was -$101500.0 (down 236.49% YoY) and the FY2025 annual result came in at -$3000.0, down 100.31% from the prior year.
- Cash from Financing Activities declined to -$101500.0 in Q2 2025, from -$26500.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $958913.0 in Q1 2024 to a low of -$101500.0 in Q2 2025.
- A 4-year average of $82662.1 and a median of $9853.0 in 2021 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 23872.82% — and 2025, when it slumped 320.55%.
- Tracing VNOV's Cash from Financing Activities over 4 years: stood at $12100.0 in 2021, then slumped by 33.96% to $7991.0 in 2023, then surged by 806.02% to $72400.0 in 2024, then slumped by 240.19% to -$101500.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$101500.0 (Q2 2025), -$26500.0 (Q1 2025), and $72400.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.63 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -1.77 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | -490.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -168.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 11.77 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -271.98 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -17.69 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 1.79 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -101,500.00 |
| Apr 30, 2025 | -101,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Oct 31, 2024 | 72,400.00 |
| Oct 31, 2024 | 72,400.00 |
| Jul 31, 2024 | 52,600.00 |
| Jul 31, 2024 | 52,600.00 |
| Apr 30, 2024 | -24,135.00 |
| Apr 30, 2024 | -24,135.00 |
| Jan 31, 2024 | 958,913.00 |
| Jan 31, 2024 | 958,913.00 |
| Oct 31, 2023 | 7,991.00 |
| Oct 31, 2023 | 7,991.00 |
| Jul 31, 2023 | 17,419.00 |
| Jul 31, 2023 | 17,419.00 |
| Jan 31, 2023 | 4,000.00 |
| Jan 31, 2023 | 4,000.00 |
| Oct 31, 2021 | 12,100.00 |
| Oct 31, 2021 | 12,100.00 |